-+ 0.00%
-+ 0.00%
-+ 0.00%

LB Pharmaceuticals Q3 EPS $(0.61) Beats $(0.63) Estimate

Benzinga·11/06/2025 13:35:01
Listen to the news
LB Pharmaceuticals (NASDAQ:LBRX) reported quarterly losses of $(0.61) per share which beat the analyst consensus estimate of $(0.63) by 3.17 percent. This is a 98.46 percent increase over losses of $(39.49) per share from the same period last year.